Cart
sales@molnova.com
LY2835219
CAS No. 1231929-97-7
LY2835219 ( —— )
Catalog No. M10915 CAS No. 1231929-97-7
LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 66 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 87 | In Stock |
|
| 100MG | 113 | In Stock |
|
| 200MG | 142 | In Stock |
|
| 500MG | 259 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2835219
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.
-
DescriptionLY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK4; CDK6
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1231929-97-7
-
Formula Weight506.59
-
Molecular FormulaC27H32F2N8
-
Purity>98%(HPLC)
-
SolubilitySoluble in DMSO
-
SMILESCCN1CCN(CC2=CN=C(NC3=NC=C(F)C(=N3)C3=CC4=C(N=C(C)N4C(C)C)C(F)=C3)C=C2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Patrick J. Roberts, et al. JNCI J Natl Y Inst (2012) 104 (6): 476-487.
molnova catalog
related products
-
Abemaciclib metaboli...
Abemaciclib metabolite M20 is an active metabolite of Abemaciclib.
-
CDK2 inhibitor 73
A potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM).
-
Ro-3306
Ro-3306 is a potent, selective, ATP-competitive CDK1 inhibitor with Ki of 35 nM against CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and >50-fold relative to CDK4/cyclin D.
